Mr. Ryan Kalt, a shareholder, reports

EARLY WARNING REPORT AND NEWS RELEASE REGARDING SECURITIES OF DIXIE GOLD INC.

Ryan Kalt has divested of common shares in Dixie Gold Inc. through the sale of 909,000 common shares. The divested securities were sold, on a direct basis, during the inclusive period of April 24, 2026, to April 27, 2026. The divested securities trigger an early warning report (Form 62-103F1), which was filed after market close on April 27, 2026, on SEDAR+ and is referenced herein, as well as this related news release.

Before selling the divested securities, the acquiror held 11,400,875 common shares (then 35.92 per cent of the issuer (alongside six million share warrants and 625,000 stock options, then being a 46.99-per-cent diluted holding, if exercised).

After selling the divested securities, the acquiror now holds 10,491,875 common shares, on a direct and indirect basis, representing approximately 33.06 per cent of the issuer (alongside six million share warrants and 625,000 stock options, being a 44.62-per-cent diluted holding, if exercised).

The divested securities were sold for an average price of 2.02 cents (aggregate proceeds of $18,330) and represent approximately 2.86 per cent of the common shares of the issuer (based on the issuer reporting 31,737,188 common shares outstanding).

The acquiror may sell securities of the issuer either on the open market or through private dispositions in the future, or may acquire securities of the issuer either on the open market or through private acquisitions in the future depending upon market conditions, the acquiror's investment objectives and/or other relevant factors. Other than the foregoing or as publicly filed, the acquiror does not have plans or any future intentions which relate to or would result in any of the other foregoing matters.

The Form 62-103F1 (Required Disclosure under the Early Warning Requirements) associated with this news release can be obtained from SEDAR+. Alternatively, to obtain a copy of the report, reach Mr. Kalt at 1-403-454-2984 or care of 1001 1 St. Southeast, Suite 200, Calgary, Alta., T2G 5G3.